ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

DMK DMK Pharmaceuticals Corporation

0.232
0.00 (0.00%)
Last Updated: 19:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
DMK Pharmaceuticals Corporation DMK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.232 19:00:00
Open Price Low Price High Price Close Price Previous Close
0.232
more quote information »

Recent News

Date Time Source Heading
3/21/202413:23EDGAR2Form 25-NSE - Notification filed by national security..
2/07/202416:19EDGAR2Form 8-K - Current report
2/06/202409:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/05/202408:00EDGAR2Form 8-K - Current report
1/31/202416:17EDGAR2Form 8-K - Current report
1/23/202416:23EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/23/202416:22EDGAR2Form 8-K - Current report
1/03/202416:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
1/03/202416:02EDGAR2Form 8-K - Current report
1/03/202416:00EDGAR2Form 8-K - Current report
12/21/202311:31EDGAR2Form 8-K - Current report
12/21/202307:15GLOBEDMK Pharmaceuticals Regains Full Rights to Commercialize..
12/04/202315:47EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/04/202315:45EDGAR2Form 8-K - Current report
11/28/202315:41EDGAR2Form 8-K - Current report
11/28/202307:05GLOBEDMK Pharmaceuticals Regains Full Rights from US WorldMeds..
11/15/202315:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/15/202315:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/15/202315:11EDGAR2Form 8-K - Current report
11/15/202315:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/14/202314:57EDGAR2Form 8-K - Current report
11/14/202306:30GLOBEDMK Pharmaceuticals Reports Third Quarter 2023 Financial..
11/13/202309:52GLOBEDMK Pharmaceuticals Announces Presentation of Preclinical..
11/02/202315:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202315:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/30/202306:30GLOBEDMK Pharmaceuticals Announces Inducement Option Grant Under..
10/25/202316:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/25/202316:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/20/202315:15GLOBEDMK Pharmaceuticals Announces Inducement Option Grant Under..
10/19/202316:07EDGAR2Form 8-K - Current report
10/19/202315:05GLOBEDMK Pharmaceuticals Restructures Executive Team to Support..
10/17/202315:37EDGAR2Form 8-K - Current report
10/17/202311:28EDGAR2Form PX14A6G - Notice of exempt solicitation submitted by..
10/12/202315:22EDGAR2Form DEFC14A - Definitive proxy statement, contested..
10/10/202305:01EDGAR2Form 8-K - Current report
10/02/202315:49EDGAR2Form PREC14A - Preliminary proxy statements, contested..
9/26/202307:37EDGAR2Form SC 13D/A - General statement of acquisition of..
9/19/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/07/202311:00GLOBEAdamis Pharmaceuticals Changes Name to DMK Pharmaceuticals..

Your Recent History

Delayed Upgrade Clock